Search anything
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
ICICI Securities maintained its Buy on South Indian Bank and raised its target to ₹56 after Q4FY26 improvements in growth, asset quality and capital ratios.
Eternal Ltd rose up to 4% after foreign headroom crossed 25%, raising expectations of full MSCI weightage in February and potential passive inflows near $390 million.
PC Jeweller shares rose up to 6.48% after it repaid all outstanding dues to two consortium banks under a September 30, 2024 settlement, targeting debt-free status this quarter.
Traders are focusing on Nifty’s 24,300 support and 24,500 resistance, with pivot levels suggesting a tight range after volatility and a strong sell technical bias.
Budget 2026 keeps both tax regimes and slabs unchanged for FY 2026-27, while draft rules update HRA and key allowances to keep the old option relevant.
TCS started FY26 earnings with net profit rising to ₹12,760 crore, but weak revenue trends, constant-currency declines, and cautious demand signals weighed on the stock and sector mood.
TCS heads into its June-quarter print amid a sharp stock correction, muted growth expectations, and heightened investor focus on AI monetisation, hiring plans, and client spending signals.
Brokerages turned cautious on Dr Reddy’s after Q4FY26 earnings missed expectations amid a steep Revlimid decline, US pricing pressure, and regulatory delays for semaglutide in Canada and Brazil.
Jefferies reiterates a Buy on Mankind Pharma with a Rs 3,000 target, as the broker tracks FY26 recovery, BSV integration and India’s semaglutide launch window.
EMS stocks including Dixon and Syrma rallied after the Budget raised the semiconductor and electronics outlay to ₹40,000 crore, alongside company-specific catalysts like a Japan JV and QIP launch.
Indian IT stocks have stayed under pressure amid AI-led pricing worries, weaker global tech spending signals, and a sharp sector-wide sell-off triggered by Accenture guidance cuts.
UBS flags early signs of an earnings recovery and renewed foreign investor engagement, with banks, staples and select cyclicals in focus despite still-rich valuations.
Crompton Greaves Consumer Electricals reported multiple MSEDCL solar water pump orders under PM-KUSUM-B, with 60-day execution timelines and five-year warranty, maintenance and remote monitoring support.
Iware Supplychain Services hit back-to-back 5% upper circuits after Vijay Kedia’s Kedia Securities bought 4.99 lakh shares, taking the combined holding to 10.35%.
Social media chatter flags a Nifty daily-chart breakdown narrative, with mixed indicator signals and well-defined support-resistance zones around 24,700 and 25,100.
Swan Defence stock is being discussed for sharp price swings, a promoter OFS plan, big order headlines, and FY26 results showing higher income but continued losses.
